Physician profile
Elizabeth Mcmahon Spiers
NPI 1861470171
$65,124.16
in general payments reported to CMS, 2019-2025
11 companies · $3,088 in 2025
The $3,088 reported for 2025 was more than what 92% of Dermatopathology (Dermatology) providers received nationally (typical 2025 total: $251).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,886 · 2020: $4,807 · 2021: $11K · 2022: $9,954 · 2023: $29K · 2024: $188 · 2025: $3,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $2,688 · Food and Beverage: $1,761 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,950.00 |
| Travel and Lodging | $2,688.48 |
| Food and Beverage | $1,761.09 |
| Education | $104.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $64,117.26 | 2019-2025 | Aklief, Oracea, Epsolay |
| Regeneron Healthcare Solutions, INC. | $425.35 | 2019-2025 | Dupixent |
| Janssen Biotech, INC. | $193.23 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $135.99 | 2023-2025 | Olumiant, Zepbound, Ebglyss |
| Hologic Sales and Service, LLC | $130.34 | 2025 | Myosure Tissue Removal Device, Acessa Provu System |
| Leo Pharma INC. | $42.94 | 2019-2023 | Adbry |
| Organon LLC | $32.83 | 2025 | |
| Incyte Corporation | $16.97 | 2024 | Jakafi, Monjuvi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.97 | 2020 | |
| Abbvie INC. | $13.05 | 2019 | |
| Prugen, INC. Pharmaceuticals | $2.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Spiers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.